Helminths and mucosal immune modulation

Annals of the New York Academy of Sciences

Volumn 1072, Issue , 2006, Pages 356-364

  Weinstock, Joel V ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; Helminths; Immune regulation; T cells; Ulcerative colitis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA;

CD8+ T LYMPHOCYTE; CELL GROWTH; CONFERENCE PAPER; CROHN DISEASE; ENTAMOEBA HISTOLYTICA; ENTERITIS; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENE EXPRESSION; GEOGRAPHIC DISTRIBUTION; HELMINTH; HYGIENE; HYMENOLEPIS DIMINUTA; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; MICROBIAL COLONIZATION; MUCOSAL IMMUNITY; NONHUMAN; PREVALENCE; RISK FACTOR; SCHISTOSOMA MANSONI; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; ULCERATIVE COLITIS; WORM;

ANIMALIA; MURINAE; VERMES;

EID: 33749013296     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1326.033     Document Type: Conference Paper

References (77)

1. LOFTUS, E.V. JR. & W.J. SANDBORN. 2002. Epidemiology of inflammatory bowel disease. Gastroenterol. Clin. North Am. 31: 1-20.
2. BACH, J.F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.
3. SUMMERS, R.W., D.E. ELLIOTT, J.F. URBAN JR., et al. 2005. Trichuris suis therapy in Crohn's disease. Gut 54: 87-90.
4. SUMMERS, R.W., D.E. ELLIOTT, J.F. URBAN JR., et al. 2005. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128: 825-832.
5. SUMMERS, R.W., D.E. ELLIOTT & J.V. WEINSTOCK. 2005. Is there a role for helminths in the therapy of inflammatory bowel disease? Nature Clin. Prac. Gastroenterol. Hepatol. 2: 62-63.
6. TYSK, C., E. LINDBERG, G. JARNEROT & B. FLODERUS-MYRHED. 1988. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 29: 990-996.
7. HALFVARSON, J., L. BODIN, C. TYSK, et al. 2003. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124: 1767-1773.
8. CUTHBERT, A.P., S.A. FISHER, M.M. MIRZA, et al. 2002. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122: 867-874.
9. ABREU, M.T., K.D. TAYLOR, Y.C. LIN, et al. 2002. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 123: 679-688.
10. RADLMAYR, M., H.P. TOROK, K. MARTIN & C. FOLWACZNY. 2002. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 122: 2091-2092.
11. CALKINS, B.M. 1989. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci. 34: 1841-1854.
12. ANDERSSON, R.E., G. OLAISON, C. TYSK & A. EKBOM. 2001. Appendectomy and protection against ulcerative colitis. N. Engl. J. Med. 344: 808-814.
13. DERBY, L.E. & H. JICK. 1998. Appendectomy protects against ulcerative colitis. Epidemiology 9: 205-207.
14. RUSSEL, M.G., E. DORANT, R.J. BRUMMER, et al. 1997. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 113: 377-382.
15. SONNENBERG, A., D.J. MCCARTY & S.J. JACOBSEN. 1991. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 100: 143-149.
16. SHIVANANDA, S., J. LENNARD-JONES, R. LOGAN, et al. 1996. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39: 690-697.
17. ELLIOTT, D.E., J.F. URBAN JR., C.K. ARGO & J.V. WEINSTOCK. 2000. Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J. 14: 1848-1855.
18. BERNSTEIN, C.N., J.F. BLANCHARD, P. RAWSTHORNE & A. WAJDA. 1999. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am. J. Epidemiol. 149: 916-924.
19. LOFTUS, E.V. JR., P. SCHOENFELD & W.J. SANDBORN. 2002. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment. Pharmacol. Ther. 16: 51-60.
20. ROLON, P.A. 1979. Gastrointestinal pathology in South America. Isr. J. Med. Sci. 15: 318-321.
21. AL SHAMALI, M.A., M. KALAOUI, I. PATTY, et al. 2003. Ulcerative colitis in Kuwait: a review of 90 cases. Digestion 67: 218-224.
22. TEZEL, A., G. DOKMECI, M. ESKIOCAK, et al. 2003. Epidemiological features of ulcerative colitis in Trakya, Turkey. J. Intern. Med. Res. 31: 141-148.
23. HUTT, M.S. 1979. Epidemiology of chronic intestinal disease in middle Africa. Isr. J. Med. Sci. 15: 314-317.
24. SEGAL, I. 1988. Ulcerative colitis in a developing country of Africa: the Baragwanath experience of the first 46 patients. Int. J. Colorectal Dis. 3: 222-225.
25. YANG, S.K., E.V. LOFTUS JR. & W.J. SANDBORN. 2001. Epidemiology of inflammatory bowel disease in Asia. Inflam. Bowel Dis. 7: 260-270.
26. PONGPRASOBCHAI, S., S. MANATSATHIT, S. LEELA KUSOLVONG, et al. 2001. Ulcerative colitis in Thailand: a clinical study and long term follow-up. J. Med. Assoc. Thailand 84: 1281-1288.
27. CARR, I. & J.F. MAYBERRY. 1999. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994). Am. J. Gastroenterol. 94: 2918-2922.
28. JAYANTHI, V., C.S. PROBERT, D. PINDER, et al. 1992. Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q. J. Med. 82: 125-138.
29. PROBERT, C.S., V. JAYANTHI, A.O. HUGHES, et al. 1993. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 34: 1547-1551.
30. WRIGHT, J.P., I.N. MARKS, C. JAMESON, et al. 1983. Inflammatory bowel disease in Cape Town, 1975-1980. Part II. Crohn's disease. S. Afr. Med. J. 63: 226-229.
31. NOVIS, B.H., I.N. MARKS, S. BANK & J.H. LOUW. 1975. Incidence of Crohn's disease at Groote Schuur Hospital during 1970-1974. S. Afr. Med. J. 49: 693-697.
32. ODES, H.S., D. FRASER & J. KRAWIEC. 1989. Inflammatory bowel disease in migrant and native Jewish populations of southern Israel. Scand. J. Gastroenterol. Suppl. 170: 36-38.
33. ODES, H.S., D. FRASER, P. KRUGLIAK, et al. 1991. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut 32: 1024-1026.
34. DUGGAN, A.E., I. USMANI, K.R. NEAL & R.F. LOGAN. 1998. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 43: 494-498.
35. GENT, A.E., M.D. HELLIER, R.H. GRACE, et al. 1994. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 343: 766-767.
36. EKBOM, A., C. HELMICK, M. ZACK & H.O. ADAMI. 1991. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 100: 350-358.
37. SONNENBERG, A. 1990. Occupational distribution of inflammatory bowel disease among German employees. Gut 31: 1037-1040.
38. DELCO, F. & A. SONNENBERG. 1998. Military history of patients with inflammatory bowel disease: an epidemiological study among U.S. veterans. Am. J. Gastroenterol. 93: 1457-1462.
39. HILDEBRAND, H., Y. FINKEL, L. GRAHNQUIST, et al. 2003. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 52: 1432-1434.
40. MOLINIE, F., C. GOWER-ROUSSEAU, T. YZET, et al. 2004. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 53: 843-848.
41. MOREELS, T.G., R.J. NIEUWENDIJK, J.G. DE MAN, et al. 2004. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 53: 99-107.
42. ELLIOTT, D.E., J. LI, A. BLUM, et al. 2003. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. 284: G385-G391.
43. KHAN, W.I., P.A. BLENNERHASSET, A.K. VARGHESE, et al. 2002. Intestinal nematode infection ameliorates experimental colitis in mice. Infect. Immun. 70: 5931-5937.
44. ELLIOTT, D.E., T. SETIAWAN, A. METWALI, et al. 2004. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur. J. Immunol. 34: 2690-2698.
45. LA FLAMME, A.C., K. RUDDENKLAU & B.T. BACKSTROM. 2003. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71: 4996-5004.
46. SEWELL, D., Z. QING, E. REINKE, et al. 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Intern. Immunol. 15: 59-69.
47. ZACCONE, P., Z. FEHERVARI, F.M. JONES, et al. 2003. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 33: 1439-1449.
48. MCINNES, I.B., B.P. LEUNG, M. HARNETT, et al. 2003. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J. Immunol. 171: 2127-2133.
49. NAGAYAMA, Y., K. WATANABE, M. NIWA, et al. 2004. Schistosoma mansoni and α-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. J. Immunol. 173: 2167-2173.
50. BASHIR, M.E., P. ANDERSEN, I.J. FUSS, et al. 2002. An enteric helminth infection protects against an allergic response to dietary antigen. J. Immunol. 169: 3284-3292.
51. MAXWELL, C., R. HUSSAIN, T.B. NUTMAN, et al. 1987. The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection. Am. J. Trop. Med. Hyg. 37: 126-134.
52. LOUKAS, A. & P. PROCIV. 2001. Immune responses in hookworm infections. Clin. Microbiol. Rev. 14: 689-703.
53. TURNER, J.D., H. FAULKNER, J. KAMGNO, et al. 2003. Th2 cytokines are associated with reduced worm burdens in a human intestinal helminth infection. J. Infect. Dis. 188: 1768-1775.
54. DUNNE, D.W. & E.J. PEARCE. 1999. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect. 1: 553-560.
55. GAUSE, W.C., J.F. URBAN JR. & M.J. STADECKER. 2003. The immune response to parasitic helminths: insights from murine models. Trends Immunol. 24: 269-277.
56. BANCROFT, A.J., K.J. ELSE, J.P. SYPEK & R.K. GRENCIS. 1997. Interleukin-12 promotes a chronic intestinal nematode infection. Eur. J. Immunol. 27: 866-870.
57. BORKOW, G., Q. LENG, Z. WEISMAN, et al. 2000. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J. Clin. Invest. 106: 1053-1060.
58. BENTWICH, Z., Z. WEISMAN, C. MOROZ, et al. 1996. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin. Exp. Immunol. 103: 239-243.
59. KULLBERG, M.C., E.J. PEARCE, S.E. HIENY, et al. 1992. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J. Immunol. 148: 3264-3270.
60. PEARLMAN, E., J.W. KAZURA, F.E. HAZLETT JR. & W.H. BOOM. 1993. Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J. Immunol. 151: 4857-4864.
61. SACCO, R., M. HAGEN, M. SANDOR, et al. 2002. Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin. Immunol. 104: 274-281.
62. SABIN, E.A., M.I. ARAUJO, E.M. CARVALHO & E.J. PEARCE. 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173: 269-272.
63. MALHOTRA, I., P. MUNGAI, A. WAMACHI, et al. 1999. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J. Immunol. 162: 6843-6848.
64. PARRELLO, T., G. MONTELEONE, S. CUCCHIARA, et al. 2000. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J. Immunol. 165: 7234-7239.
65. RENNICK, D.M. & M.M. FORT. 2000. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am. J. Physiol. 278: G829-G833.
66. GORELIK, L. & R.A. FLAVELL. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181.
67. KABASHIMA, K., T. SAJI, T. MURATA, et al. 2002. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109: 883-893.
68. LYNCH, N.R., I. HAGEL, M. PEREZ, et al. 1993. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J. All. Clin. Immunol. 92: 404-411.
69. VAN DEN BIGGELAAR, A.H., L.C. RODRIGUES, R. VAN REE, et al. 2004. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J. Infect. Dis. 189: 892-900.
70. JONULEIT, H. & E. SCHMITT. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171: 6323-6327.
71. URAUSHIHARA, K., T. KANAI, K. KO, et al. 2003. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J. Immunol. 171: 708-716.
72. LIU, H., B. HU, D. XU & F.Y. LIEW. 2003. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β and CTLA4. J. Immunol. 171: 5012-5017.
73. MOTTET, C., H.H. UHLIG & F. POWRIE. 2003. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170: 3939-3943.
74. FIELD, A.C., L. CACCAVELLI, M.F. BLOCH & B. BELLON. 2003. Regulatory CD8+ T cells control neonatal tolerance to a Th2-mediated autoimmunity. J. Immunol. 170: 2508-2515.
75. MCGUIRK, P. & K.H. MILLS. 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23: 450-455.
76. JIANG, H., S.I. ZHANG & B. PERNIS. 1992. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256: 1213-1215.
77. INCE, N.M., T. SETIAWAN, A.M. BLUM, et al. 2005. H. polygyrus induces TLR4 on murine mucosal T cells that produce TGFβ after LPS stimulation. J. Immunol. 176: 726-729.